ApurvaADesaiMD

PubMed

• 8 citations
  A phase I dose-escalation study of the polyamine analog PG-11047 in patients with advanced solid tumors
  Tracy Murray Stewart, Apurva A. Desai, Michael L. Fitzgerald, Laurence J. Marton, Robert A. Casero> ;Cancer Chemotherapy and Pharmacology. 2020 May 23
• 20 citations
  Vascular endothelial growth factor pathway
  Michael L. Maitland, Xing Jian Lou, Jacqueline Ramírez, Apurva A. Desai, Dorit S. Berlin, Howard L. McLeod, Ralph R. Weichselbaum, Mark J. Ratain, Russ B. Altman, Teri...> ;Pharmacogenetics and Genomics. 2010 May 1
• 843 citations
  Sorafenib for Treatment of Renal Cell Carcinoma: Final Efficacy and Safety Results of the Phase III Treatment Approaches in Renal Cancer Global Evaluation Trial
  Bernard Escudier, Tim Eisen, Walter M. Stadler, Cezary Szczylik, Stéphane Oudard, Michael Staehler, Sylvie Negrier, Christine Chevreau, Apurva A. Desai, Frederic Rolla...> ;Journal of Clinical Oncology. 2009 Jul 10
• 165 citations
  Phase I and Pharmacokinetic Study of Sorafenib in Patients With Hepatic or Renal Dysfunction: CALGB 60301
  , , , , , , , , , , , , , , , > ;Journal of Clinical Oncology. 2009 Apr 10
• 77 citations
  A Phase I Trial to Determine the Safety, Tolerability, and Maximum Tolerated Dose of Deforolimus in Patients with Advanced Malignancies
  Christine Hartford, Apurva A. Desai, Linda Janisch, Theodore Karrison, Victor M. Rivera, Lori Berk, John W. Loewy, Hedy L. Kindler, Walter M. Stadler, H. L. Knowles, C...> ;Clinical Cancer Research. 2009 Feb 15
• 25 citations
  A phase I and pharmacokinetic study of the quinoxaline antitumour Agent R(+)XK469 in patients with advanced solid tumours.
  Samir D. Undevia, Federico Innocenti, Jacqueline Ramírez, Larry House, Apurva A. Desai, Linda A. Skoog, D. A. Singh, Theodore Karrison, Hedy L. Kindler, Mark J. Ratain> ;European Journal of Cancer. 2008 Aug 1
• 25 citations
  A Phase I/II study of GTI-2040 and capecitabine in patients with renal cell carcinoma.
  Walter M. Stadler, Apurva A. Desai, David I. Quinn, Ronald M. Bukowski, Bernard J. Poiesz, Carl G. Kardinal, Nancy L. Lewis, Alex Makalinao, Peter Murray, Frank M. Torti> ;Cancer Chemotherapy and Pharmacology. 2008 Apr 1
• 180 citations
  Pharmacogenomic and Pharmacokinetic Determinants of Erlotinib Toxicity
  Charles M. Rudin, Wanqing Liu, Apurva A. Desai, Theodore Karrison, Xuemin Jiang, Linda Janisch, Soma Das, Jacqueline Ramírez, Balasubramanian Poonkuzhali, Erin Schuetz...> ;Journal of Clinical Oncology. 2008 Mar 1
• 29 citations
  Lack of Association between Common Polymorphisms in UGT1A9 and Gene Expression and Activity
  Jacqueline Ramírez, Wanqing Liu, Snezana Mirkov, Apurva A. Desai, Peixian Chen, Soma Das, Federico Innocenti, Mark J. Ratain> ;Drug Metabolism and Disposition. 2007 Dec 1
• 67 citations
  Phase 2 Study of ABT-510 in Patients with Previously Untreated Advanced Renal Cell Carcinoma
  Scot W. Ebbinghaus, Maha Hussain, Nizar M. Tannir, Michael S. Gordon, Apurva A. Desai, Raymond A. Knight, Rod A. Humerickhouse, Jiang Qian, Gary Gordon, Robert A. Figlin> ;Clinical Cancer Research. 2007 Nov 15
• 17 citations
  Pharmacokinetic modulation of oral etoposide by ketoconazole in patients with advanced cancer.
  Wei Peng Yong, Apurva A. Desai, Federico Innocenti, Jacqueline Ramírez, Dale R. Shepard, Ken Kobayashi, Larry House, Gini F. Fleming, Nicholas J. Vogelzang, Richard L....> ;Cancer Chemotherapy and Pharmacology. 2007 Feb 17
• 3764 citations
  Sorafenib in advanced clear-cell renal-cell carcinoma.
  Bernard Escudier, Tim Eisen, Walter M. Stadler, Cezary Szczylik, Stéphane Oudard, Michael Siebels, Sylvie Negrier, Christine Chevreau, Ewa Solska, Apurva A. Desai, Fre...> ;The New England Journal of Medicine. 2007 Jan 11
• 7 citations
  Diffuse alveolar damage after a single dose of topotecan in a patient with pulmonary fibrosis and small cell lung cancer
  Michael L. Maitland, Rebecca Wilcox, D. Kyle Hogarth, Apurva A. Desai, Phil Caligiuri, Cyril Abrahams, Ravi Salgia> ;Lung Cancer. 2006 Nov 1
• 767 citations
  Phase II placebo-controlled randomized discontinuation trial of sorafenib in patients with metastatic renal cell carcinoma
  Mark J. Ratain, Tim Eisen, Walter M. Stadler, Keith T. Flaherty, Stan B. Kaye, Gary L. Rosner, Martin Gore, Apurva A. Desai, Amita Patnaik, Henry Q. Xiong, Eric K. Row...> ;Journal of Clinical Oncology. 2006 Jun 1
• 8 citations
  Combination Therapy of Imatinib Mesylate and Interferon-α Demonstrates Minimal Activity and Significant Toxicity in Metastatic Renal Cell Carcinoma: Results of a Singl...
  Blase N. Polite, Apurva A. Desai, Beth Manchen, Walter M. Stadler> ;Clinical Genitourinary Cancer. 2006 Mar 1
• 6 citations
  Novel kinase inhibitors in renal cell carcinoma: progressive development of static agents.
  Apurva A. Desai, Walter M. Stadler> ;Current Urology Reports. 2006 Jan 1
• 13 citations
  Modulation of irinotecan with cyclosporine: a phase II trial in advanced colorectal cancer.
  Apurva A. Desai, Hedy L. Kindler, David A. Taber, Edem Agamah, Sridhar Mani, Kurombi Wade-Oliver, Mark J. Ratain, Everett E. Vokes> ;Cancer Chemotherapy and Pharmacology. 2005 May 13
• 94 citations
  Haplotypes of variants in the UDP-glucuronosyltransferase1A9 and 1A1 genes.
  Federico Innocenti, Wanqing Liu, Peixian Chen, Apurva A. Desai, Soma Das, Mark J. Ratain> ;Pharmacogenetics and Genomics. 2005 May 1
• 4 citations
  Novel kinase inhibitors in renal cell carcinoma: progressive development of static agents.
  Apurva A. Desai, Walter M. Stadler> ;Current Oncology Reports. 2005 Mar 1
• 146 citations
  A Functional Common Polymorphism in a Sp1 Recognition Site of the Epidermal Growth Factor Receptor Gene Promoter
  Wanqing Liu, Federico Innocenti, Michael H. Wu, Apurva A. Desai, M. Eileen Dolan, Edwin H. Cook, Mark J. Ratain> ;Cancer Research. 2005 Jan 1
• EGFR pharmacogenomics: the story continues to mutate and evolve.
  Apurva A. Desai, Mark J. Ratain> ;American Journal of Pharmacogenomics. 2005 Jan 1
• 4 citations
  A phase I trial of pharmacokinetic modulation of carboxyamidotriazole (CAI) with ketoconazole in patients with advanced cancer.
  Apurva A. Desai, Federico Innocenti, Linda Janisch, Mark D. DeMario, Dale R. Shepard, Jacqueline Ramírez, Gini F. Fleming, Mark J. Ratain> ;Cancer Chemotherapy and Pharmacology. 2004 Jul 3
• 38 citations
  Pharmacogenomics: road to anticancer therapeutics nirvana?
  Apurva A. Desai, Federico Innocenti, Mark J. Ratain> ;Oncogene. 2003 Sep 29
• 43 citations
  UGT pharmacogenomics: implications for cancer risk and cancer therapeutics.
  Apurva A. Desai, Federico Innocenti, Mark J. Ratain> ;Pharmacogenetics. 2003 Aug 1
• 61 citations
  Thalidomide-associated deep vein thrombosis and pulmonary embolism
  Glen T. Schumock, Apurva A. Desai, Hau C. Kwaan, Dennis W. Raisch, Rebecca Newlin, Walter M. Stadler> ;The American Journal of Medicine. 2002 Nov 1
• Join now to see all